BenevolentAI is a leading, clinical-stage AI-enabled drug discovery company.
BenevolentAI
BenevolentAI is a leading, clinical-stage AI-enabled drug discovery company.
Date Founded
2013
Founders / Management
Brent Gutekunst, Ivan Griffin, Ken Mulvany & Michael Brennan
HQ
London, England
Location(s)
UK
Website
-
LinkedIn
-
Twitter
-
Facebook
-
Instagram
-
Contact
-